BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17619825)

  • 1. Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report.
    Johnston DL; Keene DL; Lafay-Cousin L; Steinbok P; Sung L; Carret AS; Crooks B; Strother D; Wilson B; Odame I; Eisenstat DD; Mpofu C; Zelcer S; Huang A; Bouffet E
    J Neurooncol; 2008 Jan; 86(1):101-8. PubMed ID: 17619825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome and patterns of failure in patients of non-pineal supratentorial primitive neuroectodermal tumor: review of literature and clinical experience form a regional cancer center in north India.
    Biswas A; Mallick S; Purkait S; Roy S; Sarkar C; Bakhshi S; Singh M; Julka PK; Rath GK
    Acta Neurochir (Wien); 2015 Jul; 157(7):1251-66. PubMed ID: 25990846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
    Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A
    Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel case of a CAT to AAT transversion in codon 179 of the p53 gene in a supratentorial primitive neuroectodermal tumor harbored by a young girl. Case report and review of the literature.
    Postovsky S; Ben Arush MW; Elhasid R; Davidson S; Leshanski L; Vlodavsky E; Guilburd JN; Amikam D
    Oncology; 2003; 65(1):46-51. PubMed ID: 12837982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children.
    Hayden JT; Frühwald MC; Hasselblatt M; Ellison DW; Bailey S; Clifford SC
    Cell Cycle; 2009 Jun; 8(11):1806-7. PubMed ID: 19411854
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.
    Choi SH; Kim SH; Shim KW; Han JW; Choi J; Kim DS; Lyu CJ; Kim JW; Suh CO; Cho J
    PLoS One; 2016; 11(4):e0153443. PubMed ID: 27074032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term relapse-free survival with supratentorial primitive neuroectodermal tumor in an adult: a case report.
    Krampulz T; Hans VH; Oppel F; Dietrich U; Puchner MJ
    J Neurooncol; 2006 May; 77(3):291-4. PubMed ID: 16528456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
    Jakacki RI
    Childs Nerv Syst; 1999 Oct; 15(10):586-91. PubMed ID: 10550590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A
    Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    McBride SM; Daganzo SM; Banerjee A; Gupta N; Lamborn KR; Prados MD; Berger MS; Wara WM; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1319-23. PubMed ID: 18485615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
    J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primitive cerebral neuroectodermal tumors excluding medulloblastomas: a retrospective study of 30 cases.
    Mikaeloff Y; Raquin MA; Lellouch-Tubiana A; Terrier-Lacombe MJ; Zerah M; Bulteau C; Habrand JL; Kalifa C
    Pediatr Neurosurg; 1998 Oct; 29(4):170-7. PubMed ID: 9876245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.